ARLO insider tax-withholding sale: 50,018 shares at avg $17.40
Rhea-AI Filing Summary
Arlo Technologies, Inc. (ARLO) General Counsel Brian Busse reported the sale of 50,018 shares of common stock on 08/12/2025 to satisfy estimated tax withholding upon the settlement of performance stock units. The filing discloses a weighted average sale price of $17.3963 and a reported price range of $16.40–$18.47.
Following the disposal Busse beneficially owned 660,738 shares. The Form 4 identifies the transaction as a tax-withholding sale and offers to provide per-price sale details upon request.
Positive
- Transaction clearly disclosed with weighted average price and price range provided
- Sale attributed to tax withholding on PSU settlement, which is a routine, non-discretionary reason
- Reporting person retains material beneficial ownership of 660,738 shares after the transaction
Negative
- None.
Insights
TL;DR: Reported sale is a routine tax-withholding disposal tied to PSU settlement and appears procedural rather than a discretionary divestiture.
The Form 4 shows an officer and director, Brian Busse, sold 50,018 shares on 08/12/2025 specifically to satisfy tax withholding related to performance stock units. The filing provides the weighted average sale price ($17.3963) and the full reported price range. Because the disposal is identified as a withholding event rather than an open-market decision, this disclosure suggests no immediate governance change or transfer of control; Busse retains substantial beneficial ownership at 660,738 shares.
TL;DR: The transaction is informational and likely neutral for investors; it documents a tax-related disposal and post-transaction holdings.
The report quantifies a single transaction of 50,018 shares at a weighted average of $17.3963 with prices between $16.40 and $18.47. The filing’s explanation attributes the sale to tax-withholding on PSU settlement, and it records the officer’s remaining beneficial ownership of 660,738 shares. There is no indication in the filing of broader open-market selling or a 10b5-1 plan authorization, and the issuer offers to provide per-price sale details on request.